Cohance Lifesciences shares rise after USFDA Form 483
Cohance Lifesciences shares rose nearly 5.5% on Monday, Sept. 21, after the USFDA issued a Form 483 with five observations from an inspection of the company’s Jaggaiahpet API manufacturing facility.
5% on Monday, September 21, after the United States Food and Drug Administration (USFDA) issued a Form 483 containing five observations following an inspection of the company's active pharmaceutical ingredient (API) manufacturing facility at Jaggaiahpet…